Contact Info
Stuart Chalk, Ph.D.
Department of Chemistry
University of North Florida
Phone: 1-904-620-1938
Fax: 1-904-620-3535
Email: schalk@unf.edu
Website: @unf
N-Acetylprocainamide
- IUPAC Name: 4-acetamido-N-[2-(diethylamino)ethyl]benzamide
- Molecular Formula: C15H23N3O2
- CAS Registry Number: 32795-44-1
- InChI: InChI=1S/C15H23N3O2/c1-4-18(5-2)11-10-16-15(20)13-6-8-14(9-7-13)17-12(3)19/h6-9H,4-5,10-11H2,1-3H3,(H,16,20)(H,17,19)
- InChI Key: KEECCEWTUVWFCV-UHFFFAOYSA-N
Citations 1
"More-sensitive Enzyme-multiplied Immunoassay Technique For Procainamide And N-acetylprocainamide In Plasma, Serum And Urine"
Clin. Chem.
1988 Volume 34, Issue 5 Pages 957-960
PR Henry and RA Dhruv
Abstract:
Procainamide(I) and N-acetylprocainamide(II) were determined by a commercial EMIT method (Syva Co.), modified to permit automated analysis of ~100 samples per day in a working range of 0.1 to 2.0 µg mL-1. A Gilford 203S continuous-flow system was used, with a Beckman Model DU spectrophotometer. The calibration graph was prepared by using I or II concentration. of 0, 0.1, 0.2, 1.6, 1.0 and 2.0 µg mL-1 and had a standard deviation of 5%. In a study in which 0.1 to 10 µg mL-1 of I and II were determined in duplicate, average recoveries, calculated from data obtained on two separate days were 99.5% (coefficient of variation 2.2%) and 100.4% (coefficient of variation 3.0%) for I and II, respectively. At extreme ratios of I to II the accuracy of determining the lower concentration. component became unsatisfactory.
Blood Plasma
Blood Serum
Urine
Clinical analysis
Spectrophotometry
Immunoassay
Simultaneous analysis